However, whether Lp-PLA 2 is a novel biomarker or is causal in the development of atherosclerotic diseases remains controversial
If side effects are severe or persistent, the provider may adjust the dose, switch to a different GLP-1 agonist, or explore alternative treatments
Additionally, plasma is used to manufacture medications and treatments for patients with clotting disorders, immunodeficiency, and other serious conditions
reports research support grants from Akero, AstraZeneca, Boehringer Ingelheim, BMS, 89bio, Eli Lilly & Company, Intercept, IONIS, Janssen, Madrigal, Metacrine, Merck, NorthSea Therapeutics, Novartis, Novo Nordisk, Oramed, Pfizer, Poxel and Sanofi
How It Works Online Consultation: Fill out a simple online form to help us understand your medical history and current medication needs